Research
August 2, 2010
HIV, aging have negative impact
Although individuals who are HIV positive can now expect to live longer because of the availability of anti-retroviral drugs, this advance brings on new health challenges. It is estimated that the majority of the HIV-infected population of the United States will be older than 50 by 2015.
The intersection of aging and HIV infection appears to have a destructive impact on bone health. Emory researchers have shown in an animal model that the presence of HIV proteins, even without a replicating virus, leads to alterations in cells that break down bone.
The team’s results were published online July 19 in the Early Edition of the Proceedings of the National Academy of Sciences.
“We found that HIV proteins, by themselves, can alter the output of hormones that affect the balance between bone formation and bone breakdown leading to bone loss,” says endocrinologst M. Neale Weitzmann. “This information could help doctors decide the best way to stave off osteoporosis and bone fractures, which are becoming increasingly common in individuals living with HIV infection.”
The Emory team studied rats that have an HIV virus that cannot replicate incorporated into their DNA. The virus does not kill white blood cells directly as it does in human patients, but parts of the virus appear in the rats’ blood, and appear to distort the function of immune cells.
Compared to normal rats, the HIV-transgenic rats’ bone mineral density (determined by X-rays) in the femur was reduced by 36 percent, while the proportion of bone in the spongy areas of their femurs was reduced by 32 percent.
The authors found that HIV-transgenic rats have more osteoclasts — cells that originate in the bone marrow that break down bone. This is because their B cells produce more of certain hormones that promote osteoclast differentiation.
Previous studies have shown that viral infection drives changes in the balance of the types of B cells present in HIV-infected people. Weitzmann says the next step in the team’s research will be to examine B cell subpopulations in HIV-infected people, and to measure their output of hormones involved in bone growth and breakdown.
